Ken Griffin’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Ken Griffin’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,000	Closed	-$60K	–	15558
2023 Q3	$60K	Buy	9,000 +5,100	+131%	+$42.4K	﹤0.01%	11535
2023 Q2	$35.3K	Sell	3,900 -1,300	-25%	-$11.5K	﹤0.01%	12182
2023 Q1	$37.8K	Buy	+5,200	New	+$38.6K	﹤0.01%	12491

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Ken Griffin's PNT Position: Q4 2023 in Review

Ken Griffin sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 2,157,166 shares — an estimated $14.4M sold.

Ken Griffin first reported a position in PNT in Q3 2020 and held it in 13 quarters. The position peaked at $28.4M in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Ken Griffin reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Ken Griffin sold 2,157,166 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $14.4M.
Ken Griffin first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 13 quarters.
Ken Griffin's POINT Biopharma Global Inc. Common Stock position peaked at $28.4M in Q3 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.